Zacks Research Issues Negative Estimate for STERIS Earnings

STERIS plc (NYSE:STE) – Analysts at Zacks Research reduced their Q4 2025 earnings per share (EPS) estimates for shares of STERIS in a research report issued to clients and investors on Tuesday, February 25th. Zacks Research analyst R. Department now anticipates that the medical equipment provider will earn $2.59 per share for the quarter, down from their prior forecast of $2.60. The consensus estimate for STERIS’s current full-year earnings is $9.08 per share. Zacks Research also issued estimates for STERIS’s Q3 2026 earnings at $2.52 EPS, Q4 2026 earnings at $2.71 EPS and FY2026 earnings at $9.90 EPS.

STERIS (NYSE:STE) last issued its earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.33 by ($0.01). STERIS had a net margin of 8.66% and a return on equity of 13.91%.

STE has been the subject of several other reports. Stephens restated an “overweight” rating and set a $240.00 price objective on shares of STERIS in a research report on Thursday, February 6th. Needham & Company LLC reissued a “hold” rating on shares of STERIS in a report on Friday, November 8th. JMP Securities reaffirmed a “market outperform” rating and issued a $265.00 price objective on shares of STERIS in a report on Thursday, February 6th. Finally, Piper Sandler lifted their target price on STERIS from $260.00 to $265.00 and gave the stock an “overweight” rating in a report on Monday, February 3rd. One analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat, STERIS has an average rating of “Moderate Buy” and an average price target of $258.75.

STERIS Stock Performance

Shares of STE stock opened at $219.89 on Friday. STERIS has a 52 week low of $197.82 and a 52 week high of $248.24. The company has a market capitalization of $21.60 billion, a price-to-earnings ratio of 46.69 and a beta of 0.84. The company has a 50-day simple moving average of $214.76 and a 200 day simple moving average of $223.11. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.40 and a current ratio of 2.13.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the business. Mirae Asset Global Investments Co. Ltd. increased its position in STERIS by 25.7% during the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 8,387 shares of the medical equipment provider’s stock worth $2,005,000 after purchasing an additional 1,713 shares in the last quarter. Wealth Enhancement Advisory Services LLC increased its holdings in shares of STERIS by 32.8% during the third quarter. Wealth Enhancement Advisory Services LLC now owns 7,705 shares of the medical equipment provider’s stock worth $1,869,000 after buying an additional 1,904 shares in the last quarter. State of Alaska Department of Revenue lifted its stake in shares of STERIS by 6.9% in the 3rd quarter. State of Alaska Department of Revenue now owns 11,455 shares of the medical equipment provider’s stock valued at $2,778,000 after acquiring an additional 735 shares during the last quarter. First Trust Direct Indexing L.P. boosted its holdings in shares of STERIS by 46.3% during the 3rd quarter. First Trust Direct Indexing L.P. now owns 4,603 shares of the medical equipment provider’s stock valued at $1,116,000 after acquiring an additional 1,456 shares in the last quarter. Finally, Diversify Wealth Management LLC grew its position in STERIS by 7.8% during the 3rd quarter. Diversify Wealth Management LLC now owns 4,222 shares of the medical equipment provider’s stock worth $934,000 after acquiring an additional 304 shares during the last quarter. Institutional investors and hedge funds own 94.69% of the company’s stock.

STERIS Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, March 21st. Investors of record on Thursday, February 20th will be paid a $0.57 dividend. This represents a $2.28 annualized dividend and a yield of 1.04%. The ex-dividend date of this dividend is Thursday, February 20th. STERIS’s dividend payout ratio (DPR) is presently 48.41%.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.